Ultragenyx Pharmaceutical Inc (RARE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RARE Giù? Forum Previsione Frazionamento azionario

Ultragenyx Pharmaceutical Inc Azioni (RARE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	19.53% 166.50	139.29	139.49	147.03	108.83
Operating Expenses	2.78% 274.38	282.23	271.48	263.39	274.18
Benefits Costs and Expenses	2.96% 280.50	289.06	272.71	277.77	279.06
Costs And Expenses	2.96% 280.50	289.06	272.71	277.77	279.06
Operating Income/Loss	24.52% -107.89	-142.94	-131.99	-116.36	-165.35
Income/Loss From Continuing Operations Before Tax	23.88% -114.00	-149.77	-133.21	-130.74	-170.23
Income Tax Expense/Benefit	27.71% 0.947	1.31	0.303	0.858	0.455
Income/Loss From Continuing Operations After Tax	23.91% -114.95	-151.08	-133.52	-131.60	-170.68
Net Income/Loss	23.91% -114.95	-151.08	-133.52	-131.60	-170.68
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2.26% 98.46	96.29	95.49	86.58	84.29
Diluted Average Shares	2.26% 98.46	96.29	95.49	86.58	84.29
Basic Earnings Per Share	25.48% -1.17	-1.57	-1.40	-1.52	-2.03
Diluted Earnings Per Share	25.48% -1.17	-1.57	-1.40	-1.52	-2.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$24.87

0.96%

INCY

$84.61

1.09%

SMMT

$23.70

2.95%

BNTX

$100.00

1.89%

INSM

$136.10

0.84%

ONC

$306.05

2.72%